newsblood eosinophilsCOPD
Mepolizumab and Blood Eosinophil Variability in COPD: A New Dimension in Targeted Therapy
By MedXY|Jun 13, 2026
This article reviews mepolizumab efficacy in COPD patients with variable blood eosinophil counts, showing benefits even with intermittent eosinophilia, expanding treatable phenotypes beyond persistent elevation.